[5] The British Society of Gastroenterology Endoscopy Committee. Guidelines for decontamination of equipment for gastrointestinal endoscopy. 2014. Available at: http://www.bsg.org.uk/clinical-guidance/general/guidelines-for-decontamination-of-equipment-for-gastrointestinal-endoscopy.html. Accessed October 12, 2015
[6] Rutala WA, Weber DJ; Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for disinfection and sterilization in healthcare facilities, 2008. Available at: http://www.cdc.gov/hicpac/Disinfection_Sterilization/3_0disinfectEquipment.html. Accessed August 15, 2016
[7] Hospital Infection Control Professional Advisory Committee (HICPAC), Centers for Disease Control and Prevention (CDC). Essential elements of a reprocessing program for flexible endoscopes – Recommendations of the Healthcare Infection Control Practices Advisory Committee. 2016. Available at: https://www.cdc.gov/hicpac/pdf/Flexible-Endoscope-Reprocessing.pdf. Accessed September 1, 2017
[8] Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling Guidance for Industry and Food and Drug Administration Staff, Appendix A - Definitions. https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-med-dev-gen/documents/document/ucm253010.pdf. Accessed Sept 1, 2017.
[9] Food and Drug Administration. Reprocessing medical devices in health care settings: validation methods and labeling—guidance for industry and food and drug administration staff. March 17, 2015. Available at: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM253010.pdf. Accessed August 10, 2016
[10] Food and Drug Administration. Guidance for industry: sterile drug products produced by aseptic processing—current good manufacturing practice. 2004. Available at: https://webcache.googleusercontent.com/search?q=cache:XRs-8gHSVGKYJ:https://www.fda.gov/downloads/Drugs/Guidances/ucm070342.pdf+&cd=1&hl=en&ct=clnk&gl=us. Accessed September 1, 2017.
[11] Spaulding EH. Chemical disinfection and antisepsis in the hospital. J Hosp Res. 1972; 9:5–31
[12] Funk SE, Reaven NL. High-level endoscope disinfection processes in emerging economies: financial impact of manual process versus automated endoscope reprocessing. J Hosp Infect. 2014; 86(4):250–254
[13] Alfa MJ, Degagne P, Olson N. Worst-case soiling levels for patient-used flexible endoscopes before and after cleaning. Am J Infect Control. 1999; 27(5):392–401
[14] Chu NS, McAlister D, Antonoplos PA. Natural bioburden levels detected on flexible gastrointestinal endoscopes after clinical use and manual cleaning. Gastrointest Endosc. 1998; 48(2):137–142
[15] Rutala WA, Weber DJ. ERCP scopes: what can we do to prevent infections? Infect Control Hosp Epidemiol. 2015; 36(6):643–648
[16] Komanduri S, Abu Dayyeh BK, Bhat YM, et al; ASGE Technology Committee. Technologies for monitoring the quality of endoscope reprocessing. Gastrointest Endosc. 2014; 80(3):369–373
[17] Visrodia K, Hanada Y, Pennington KM, et al. Duodenoscope reprocessing surveillance with adenosine triphosphate testing and terminal cultures: a clinical pilot study. Gastrointest Endosc. 2017:S0016–5107(17)31782–0
[18] Alfa MJ, Olson N, Murray BL. Comparison of clinically relevant benchmarks and channel sampling methods used to assess manual cleaning compliance for flexible gastrointestinal endoscopes Am J Infect Control. 2014; 42(1):e1–e5
[19] Food and Drug Administration. FDA-cleared sterilants and high level disinfectants with general claims for processing reusable medical and dental devices - March 2015. Available at: https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/ReprocessingofReusableMedicalDevices/ucm437347.htm. Accessed August 28, 2016
[20] Rutala WA, Weber DJ. Disinfection, sterilization, and antisepsis: an overview. Am J Infect Control. 2016; 44(5, Suppl):e1–e6
[21] Desilets D, Kaul V, Tierney WM, et al; ASGE Technology Committee. Automated endoscope reprocessors. Gastrointest Endosc. 2010; 72(4):675–680
[22] Kovaleva J, Peters FT, van der Mei HC, Degener JE. Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy. Clin Microbiol Rev. 2013; 26(2):231–254
[23] Petersen BT. Duodenoscope reprocessing: risk and options coming into view. Gastrointest Endosc. 2015; 82(3):484–487
[24] Petersen BT, Ginsburg GG, Koch J. Infection using ERCP endoscopes. Gastroenterology. 2016; 151(1):46–50
[25] Epstein L, Hunter JC, Arwady MA, et al. New Delhi metallo-β-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes. JAMA. 2014; 312(14):1447–1455
[26] Wendorf KA, Kay M, Baliga C, et al. Endoscopic retrograde cholangiopancreatography-associated AmpC Escherichia coli outbreak. Infect Control Hosp Epidemiol. 2015; 36(6):634–642
[27] Alrabaa SF, Nguyen P, Sanderson R, et al. Early identification and control of carbapenemase-producing Klebsiella pneumoniae, originating from contaminated endoscopic equipment. Am J Infect Control. 2013; 41(6):562–564
[28] Gastmeier P, Vonberg RP. Klebsiella spp. in endoscopy-associated infections: we may only be seeing the tip of the iceberg. Infection. 2014; 42(1):15–21
[29] Verfaillie CJ, Bruno MJ, Voor in ’t Holt AF, et al. Withdrawal of a novel-design duodenoscope ends outbreak of a VIM-2-producing Pseudomonas aeruginosa. Endoscopy. 2015; 47(6):493–502
[30] United States Senate. Preventable tragedies: superbugs and how ineffective monitoring of medical device safety fails patients. Available at: http://www.help.senate.gov/imo/media/doc/Duodenoscope%20Investigation%20FINAL%20Report.pdf. Accessed February 16, 2016
[31] Ross AS, Baliga C, Verma P. A quarantine process for the resolution of duodenoscope-associated transmission of multidrug-resistant Escherichia coli. Gastrointest Endosc. 2015; 82(3):477–483
[32] US Food and Drug Administration. Design of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes may impede effective cleaning: FDA safety communication. Available at: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm434871.htm. Accessed August 30, 2016
[33] US Food and Drug Administration (FDA). Supplemental measures to enhance reprocessing: FDA safety communication. Available at: www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm454766.htm. Accessed August 30, 2016
[34] Chapman CG, Siddiqui UD, Manzano M, et al. Risk of infection transmission in curvilinear array echoendoscopes: results of a prospective reprocessing and culture registry. Gastrointest Endosc. 2017; 85(2):390–397.e1
[35] Visrodia K, Petersen BT. Echoing concerns related to endoscope reprocessing. Gastrointest Endosc. 2017; 85(2):398–400
[36] Weber DJ, Rutala WA. Assessing